Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 22 analyst ratings
Buy
Strong Buy 27%
Buy 59%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

UnitedHealth Group is a leader in the health insurance industry with a strong global presence and a diversified portfolio of products and services. With its large scale and successful business strategies, UnitedHealth Group has demonstrated its ability to adapt and innovate in response to changes in the market. The company's strong financial performance, particularly in its Optum franchise, positions it well for future growth and success.

Bears say

UnitedHealth Group is facing several challenges in its Optum Health division, with the target margin being lowered to 6-8% due to ongoing difficulties in the business. There are also concerns about increased utilization and pricing issues in the future, leading to a bearish case scenario. Additionally, there is a risk of underperformance in a market correction or recession, especially for highly-valued and leveraged companies like UnitedHealth. However, there is potential for upside if the company can improve margins and decrease medical costs, and if regulatory changes favor the MA industry. The v28 risk model changes and potential for higher commercial and Medicaid costs, along with regulatory scrutiny, further complicate the outlook for UnitedHealth.

UnitedHealth Group (UNH) has been analyzed by 22 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 59% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 22 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $449.77, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $449.77, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.